New Regulatory Director
2025-05-14 02:59:59

Dr. Saho Murakami Named Regulatory Director at InnoJin Co., Ltd.

Dr. Saho Murakami Appointed as Regulatory Director at InnoJin Co., Ltd.



InnoJin Co., Ltd., a Tokyo-based startup focused on innovating medical devices through cutting-edge digital technologies, has announced the appointment of Dr. Saho Murakami as its Regulatory Director effective from March 1, 2025. Dr. Murakami, an ophthalmologist with significant experience as a medical device reviewer at the Pharmaceuticals and Medical Devices Agency (PMDA), brings a wealth of expertise to her new role.

Background of InnoJin Co., Ltd.


Founded in December 2020, InnoJin is dedicated to the research, development, authorization, and commercialization of medical devices, particularly those utilizing digital technology to advance healthcare. As a university-based startup, InnoJin aims for the digital transformation (DX) of the medical field. The addition of Dr. Murakami to the team is expected to accelerate their groundbreaking research initiatives and refine regulatory strategies.

Dr. Saho Murakami's Professional Journey


Dr. Murakami holds an impressive academic and professional background:
  • - 2009: Graduated from Kyoto University with a degree in Economics.
  • - 2015: Earned her medical degree from Okayama University.
  • - 2017: Joined Keio University’s Department of Ophthalmology.
  • - 2021-2024: Worked at the PMDA, focusing on regulatory affairs for pharmaceuticals and medical devices.
  • - 2025: Transitioned to InnoJin Co., Ltd. as Regulatory Director.

Her dual experience as both a practicing clinician and a regulatory reviewer positions Dr. Murakami uniquely to spearhead InnoJin's goals, particularly in aligning regulatory requirements with innovative solutions that meet patient needs.

Dr. Murakami's Vision


Expressing her excitement upon taking on this new challenge, Dr. Murakami stated, "While I have been involved in clinical practice as an ophthalmologist, my role as a PMDA reviewer allowed me to contribute to the development and approval processes of pharmaceuticals and medical devices. I believe that combining insights from the unmet needs observed in clinical settings and the regulatory knowledge gained at the PMDA is essential to delivering innovative medical devices to society efficiently and effectively. InnoJin's mission of 'human-friendly digital healthcare' perfectly aligns with my vision for the future of medicine. As Regulatory Director, I will lead the regulatory strategy from formulation to post-approval implementation, maximizing my experience to achieve the company’s vision."

Overview of InnoJin Co., Ltd.


  • - Established: December 1, 2020
  • - Headquarters: 2-5-2 Hongo, Bunkyo-ku, Tokyo, Japan
  • - Contact Number: 03-6670-8993
  • - Website: InnoJin Website

Business Activities


InnoJin specializes in utilizing IT solutions in medical and healthcare sectors, including:
  • - Information collection, analysis, and dissemination in healthcare.
  • - Planning, production, and distribution of digital and web content related to health.
  • - Consulting services in the healthcare field.
  • - Research and education initiatives in health.
  • - Publishing various printed and electronic health-related materials.

As a rising player in the healthcare landscape, InnoJin aims to address pressing medical needs through digital innovation and strategic regulatory engagement, with Dr. Murakami leading the charge. The company looks forward to her contributions in advancing the future of medical devices in Japan and beyond.


画像1

画像2

画像3

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.